Form D · Biotechnology

ProNAi Therapeutics Inc

Plymouth, MI · CIK 0001290149

Offering snapshot reported May 1, 2014 · SEC filing

Reported sold
$59.5M
Offering amount: $59.5M
Investors reported
57
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 17, 2014
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 1, 2014Initial$59,500,000No comparison57SEC filing
Dec 31, 2013Initial$11,176,453No comparison45SEC filing
Jun 4, 2013Amendment$4,300,993$3,990,993vs Apr 4, 201237SEC filing
Apr 4, 2012Initial$310,000No comparison13SEC filing
Dec 28, 2010Amendment$1,691,410No comparison16SEC filing
Apr 7, 2009Amendment$685,130No comparisonNot reportedSEC filing
Sep 25, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-216611

Source: Form D, filed May 1, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Charles Bisgaier Director
Albert Cha Director
Robert Forgey Director, Executive
Jack Luderer Director
Richard Messman Executive
Richard Messmann Executive
Donald Parfet Director
John Puisis Director
John Puisus Director
Wendi Rodrigueza Executive
Mina Sooch Executive
Peter Thompson Director
James Topper Director
Alvin Vitangcol Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
46701 Commerce Center Drive
Plymouth, MI, 48170